Literature DB >> 15136026

Priapism.

Hossein Sadeghi-Nejad1, Vikram Dogra, Allen D Seftel, Mamdouh A Mohamed.   

Abstract

Priapism is a relatively uncommon condition that may present as a medical emergency associated with significant pain and anxiety in the veno-occlusive or low-flow variant. Pharmacologic advances and, specifically, the availability of intracavemosal alpha-agonist therapy have dramatically improved the prospects of resolution for patients with low-flow priapism presenting within the first few hours of the acute episode. High-flow priapism is not considered an emergency and treatment measures are typically conservative aimed at preservation of potency. Urologists, radiologists, and other health care personnel caring for the patient with priapism must be familiar with various etiologic factors implicated in low-flow and high-flow priapism to formulate a logical step-care approach. Differentiation of the low-flow from the high-flow state is perhaps the most critical initial diagnostic challenge that determines the sequence of further interventions including surgical shunts in low-flow priapism refractory to medical therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15136026     DOI: 10.1016/j.rcl.2004.01.008

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  3 in total

1.  Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil.

Authors:  J R Haaga; A Exner; B Fei; A Seftel
Journal:  Int J Impot Res       Date:  2006-05-25       Impact factor: 2.896

2.  Malignant priapism secondary to adenocarcinoma of the prostate.

Authors:  Charles A Kitley; Andrew D Mosier; Joren Keylock; David Nguyen
Journal:  BMJ Case Rep       Date:  2010-10-12

Review 3.  Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie's patients.

Authors:  Pengbo Jiang; Athena Christakos; Mina Fam; Hossein Sadeghi-Nejad
Journal:  Korean J Urol       Date:  2014-10-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.